“As the first and only sirolimus drug-eluting balloon approved in the United States, Selution SLR DEB introduces a groundbreaking therapy for the treatment of coronary in-stent restenosis.” Cordis President of Americas Matt Muscari said in the announcement. “This innovative device will enable physicians to address one of the most complex coronary clinical challenges.”
